Disease | infantile neuroaxonal dystrophy |
Comorbidity | C0028754|obesity |
Sentences | 1 |
PubMedID- 20582183 | Therefore, pharmacotherapy for obesity, as part of an integrated management plan, is beneficial for maintaining wt loss, optimising glycemic control and probably delaying progression of the disease[2]. |
Page: 1